Customer Center
Login | Register


VERIGENE® Respiratory Tract Infection Tests

Respiratory tract infections pose a significant diagnostic challenge because of the breadth of known pathogens and the non-specific nature of symptoms

Respiratory Tract Infections


Infections caused by influenza A and B viruses (the flu) and respiratory syncytial virus (RSV) are associated with seasonal outbreaks and are collectively responsible for a majority of respiratory illnesses.


Other respiratory pathogens such as adenoviruses, human metapneumovirus, parainfluenza, and Bordetella pertussis are also associated with significant morbidity and mortality.1-6


As is the case with other infectious diseases, respiratory infections often require a positive identification of the causative agent in order to direct optimal patient treatment. Underscoring the need for rapid and accurate testing, the most commonly prescribed antiviral medications are most effective when administered within 48 hours of the onset of symptoms.7



Flu is highly contagious and affects up to 20% of the population each year. It is responsible for more than 200,000 hospitalizations, and as many as 49,000 deaths each year, depending on the severity of the season.8 Influenza can lead to serious complications such as pneumonia, bronchitis, sinus infections, and a general worsening of chronic conditions.9

Respiratory Pathogens


Respiratory pathogens are responsible for more than one billion annual cases of the common cold and other related illnesses.10 They are recognized as a serious contributor to respiratory ailments in children, the elderly, and the immunocompromised and commonly mistreated with unnecessary antibiotics due to delays in diagnosis.11

The VERIGENE Difference


The VERIGENE® Respiratory Pathogens Flex (RP Flex) provides viral identification information clinicians need to select appropriate treatment for their patients. VERIGENE RP Flex can limit misuse and overuse of antibiotics, which are ineffective and not indicated for viral infections, and provide results within two hours. As a result, the VERIGENE System provides better patient care, reduced morbidity and mortality, improved surveillance, and a minimized spread of nosocomial infections.


The VERIGENE® Respiratory Pathogens Flex (RP Flex) is an automated, multiplexed, flexible nucleic acid test for the identification of the viruses and bacteria that most commonly cause respiratory infections.
Read More


  1. Centers for Disease Control and Prevention (CDC). Seasonal Influenza Q & A. (Accessed December 2013).
  2. Centers for Disease Control and Prevention (CDC). Respiratory Syncytial Virus Infection (RSV): Frequently Asked Questions. (Accessed December 2013).
  3. Centers for Disease Control and Prevention (CDC). Adenovirus: Clinical Overview. (Accessed December 2013).
  4. Kahn JS. Epidemiology of Human Metapneumovirus. Clin Microbiol Rev 2006; 19: 546-547.
  5. Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ. Human Parainfluenza Virus-Associated Hospitalizations Among Children Less Than Five Years of Age in the United States. Pediatr Infect Dis J 2001; 20: 646-653.
  6. Centers for Disease Control and Prevention (CDC). MMWR Weekly (2005; 54(50):1283-1286): Pertussis – United States, 2001-2003.
  7. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults: Systematic Review and Meta-Analysis. BMJ DOI: (Accessed December 2013).
  8. Centers for Disease Control and Prevention (CDC). Seasonal Influenza (Flu) – Flu Symptoms & Severity. (Accessed December 2013).
  9. Centers for Disease Control and Prevention (CDC). RSV: Frequently Asked Questions. (Accessed December 2013).
  10. Centers for Disease Control and Prevention (CDC). Common Colds: Protect Yourself and Others. (Accessed December 2013).
  11. Gilbert DN, Spellberg B, Bartlett JG. An unmet need: rapid molecular diagnostics tests for respiratory tract infections. Clin Infect Dis 2011; 52: S384-S395.


For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.